Efficacy and Safety of Bolus Injection of a Novel Thrombolytic Agent (SMRX-11) in Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI): A Phase II Open-Label, Dose-Escalation, Multicentre, Angiographic Trial - SMRX-11
开始日期2014-03-10
申办/合作机构-
100 项与 SMRX-11 相关的临床结果
登录后查看更多信息
100 项与 SMRX-11 相关的转化医学
登录后查看更多信息
100 项与 SMRX-11 相关的专利(医药)
登录后查看更多信息
1
项与 SMRX-11 相关的文献(医药)
2000-03-16·Report on medical guidelines & outcomes research
Clot-buster proves safe, effective when given during first three hours after a stroke.